Sumalpong, Rachel Jane .

HRN: 23-81-28  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2023
CEFUROXIME 1.5GM (VIAL)
11/09/2023
11/16/2023
IV
1.5g
Q8
Iufd
Waiting Final Action 
03/05/2025
CEFTRIAXONE 1G (VIAL)
03/05/2025
03/11/2025
IV
2 Grams
Q24
UTI
Waiting Final Action 
03/05/2025
CEFTRIAXONE 1G (VIAL)
03/05/2025
03/11/2025
IV
2 Grams
Q24
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: